AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Protagonist Therapeutics, Inc Director's Dealing 2019

Jan 10, 2019

31163_dirs_2019-01-09_e6d4472e-f50c-4942-a324-c6ff04df4cef.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2019-01-07

Reporting Person: Gupta Suneel (EVP Clinical Operations)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Direct